Catalyst Capital Advisors LLC - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 39 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$10,0000.0%400
-20.0%
0.00%
Q4 2018$10,000
-23.1%
5000.0%0.00%
Q3 2018$13,0005000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders